FDA Approves Verquvo

FDA Approves Verquvo FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction KENILWORTH, N.J.--(BUSINESS WIRE) January 20, 2021-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the

FDA Approves Cabenuva and Vocabria

FDA Approves Cabenuva and Vocabria FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV Treatment London, 21 January 2021 – ViiV Healthcare, the global specialist HIV company ma

AHA News: Keeping Your Brain Sharp Isnt About Working More Puzzles

AHA News: Keeping Your Brain Sharp Isnt About Working More Puzzles THURSDAY, Jan. 21, 2021 (American Heart Association News) -- Mental decline is one of the most feared aspects of growing older. People will do just about anything to prevent it, from swal

More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months

Smoking Raises Risk for Deadly Bleeding Strokes

Smoking Raises Risk for Deadly Bleeding Strokes THURSDAY, Jan. 14, 2021 -- Theres yet another reason to quit smoking: It increases the risk of deadly bleeding strokes, a new study warns. Researchers focused on a type of stroke called subarachnoid hemo

Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland

Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 12, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that